# Tack Optimized Balloon Angioplasty Post-Market Study

> **NCT05361967** · — · TERMINATED · sponsor: **Spectranetics Corporation** · enrollment: 6 (actual)

## Conditions studied

- PAD - Peripheral Arterial Disease
- PAD
- Dissection
- Arterial Dissection
- Peripheral Arterial Disease
- Peripheral Vascular Diseases

## Interventions

- **DEVICE:** The Tack Endovascular System

## Key facts

- **NCT ID:** NCT05361967
- **Lead sponsor:** Spectranetics Corporation
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** TERMINATED
- **Start date:** 2023-03-30
- **Primary completion:** 2024-06-01
- **Final completion:** 2024-06-01
- **Target enrollment:** 6 (ACTUAL)
- **Why stopped:** Terminated due to slow enrollment
- **Last updated:** 2024-08-09


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05361967

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05361967, "Tack Optimized Balloon Angioplasty Post-Market Study". Retrieved via AI Analytics 2026-06-03 from https://api.ai-analytics.org/clinical/NCT05361967. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*